American Gene Technologies (AGT) has received approval for the U.S. Food and Drug Administration to begin testing a potential cure for HIV.

The gene therapy works by altering the immune system of a patient, allowing them to fight off the virus and permanently eliminate it from their body. 

This move represents a massive step forward for the medical care community. 

“AGT developed a new treatment to repair immune system damage done by HIV and allow natural responses to control the virus,” the company says in a statement.

 “From its research, AGT believes a cure is attainable and is now taking the significant step of testing in humans.”

Right now, there are currently around 38 million people in the world who are infected with HIV. 

Although we have effective treatments, right now there is no cure. Hopefully, with successful trials, AGT can change that forever.